Edition:
India

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

561.55INR
18 Apr 2019
Change (% chg)

Rs2.20 (+0.39%)
Prev Close
Rs559.35
Open
Rs562.00
Day's High
Rs566.65
Day's Low
Rs553.20
Volume
2,306,549
Avg. Vol
2,246,925
52-wk High
Rs678.45
52-wk Low
Rs483.75

Select another date:

Fri, Apr 5 2019

BUZZ-India's Cipla rises after U.S. FDA closes inspection at Goa unit

** Shares of generic drugmaker Cipla Ltd rise as much as 3.41 pct to 538.75 rupees, their highest in a fortnight

Cipla third-quarter profit falls as lean India sales, tax cost weigh

Cipla Ltd, India's second-largest generic drugmaker by market capitalisation, reported on Wednesday a 17.1 percent drop in quarterly profit, dragged down by higher tax expenses and weak sales in domestic market.

UPDATE 1-India's Cipla Q3 profit falls as lean India sales, tax cost weigh

Feb 6 Cipla Ltd, India's second-largest generic drugmaker by market capitalisation, reported on Wednesday a 17.1 percent drop in quarterly profit, dragged down by higher tax expenses and weak sales in domestic market.

Indian shares end higher for fifth session

Feb 6 Indian shares ended higher for a fifth straight session on Wednesday, with gains across most verticals, as investor sentiment was buoyed by a slew of upbeat quarterly results ahead of a key central bank policy meet which concludes on Thursday.

India's Cipla Q3 profit falls, lags estimate

Feb 6 Cipla Ltd, India's second-biggest generic drugmaker by market capitalisation, reported a 17.1 percent fall in third-quarter profit on Wednesday, hurt by higher tax expenses.

BUZZ-India's Cipla hits near 5-month low on Q2 profit miss

** Shares of Cipla Ltd fall as much as 7.73 pct to 560.2 rupees, lowest since June 12

Cipla warns of headwinds in second half after second-quarter profit miss

Cipla Ltd, India's second-largest drugmaker by market capitalisation, warned on Monday of "multiple headwinds" in the second half of the financial year after its quarterly profit fell short of analysts' estimates.

UPDATE 1-India's Cipla warns of headwinds in second half after Q2 profit miss

Nov 5 Cipla Ltd, India's second-largest drugmaker by market capitalisation, warned on Monday of "multiple headwinds" in the second half of the financial year after its quarterly profit fell short of analysts' estimates.

India's Cipla Q2 profit dips nearly 11 pct, misses estimate

Nov 5 Drugmaker Cipla Ltd posted a nearly 11 percent fall in second-quarter profit on Monday, much lower than analyst expectations.

Select another date: